[Medication adherence in patients with chronic diseases: significance and new approaches].
Many patients post stroke or with other chronic diseases do not continue to take their evidence-based medication. Patients with reduced medication adherence are characterized by increased cardiovascular morbidity and mortality. The number of elderly individuals with chronic conditions requiring polypharmacy will continue to increase. The following strategies are discussed to enhance adherence: individual advice and continuous counselling of the patients and the caregivers, individualized pharmacotherapy, and medication management including combination pills and unit doses. Medication adherence represents a field of research with increasing importance for patient outcomes and healthcare costs. Measures to improve adherence may be equally important to the development of novel drugs. However, prospective clinical studies evaluating the effects of the proposed interventions on clinical endpoints are rare and therefore evidence-based recommendations are missing.
Klinik für Innere Medizin III; Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, 66421, Homburg/Saar, Deutschland. ulrich@laufs.com
U
U
Laufs
D002318:Cardiovascular Diseases / Q000401:mortality* / Q000517:prevention & control*; D002908:Chronic Disease / Q000401:mortality* / Q000517:prevention & control*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015995:Prevalence; D020521:Stroke / Q000401:mortality* / Q000517:prevention & control*; D016019:Survival Analysis; D015996:Survival Rate; D016903:Drug Monitoring
Stroke. 2010 Feb;41(2):397-401
20075360
Circulation. 2009 Jun 16;119(23):3028-35
19528344
JAMA. 2007 Jan 10;297(2):177-86
17213401
J Gen Intern Med. 2002 Jul;17(7):504-11
12133140
J Psychiatr Pract. 2009 Jan;15(1):34-44
19182563
Arch Intern Med. 1988 Sep;148(9):2013-6
3046541
Am J Crit Care. 1998 May;7(3):168-74
9579241
Ann Behav Med. 2003 Aug;26(1):24-31
12867351
Arch Intern Med. 1999 Nov 22;159(21):2553-60
10573045
Vasc Health Risk Manag. 2009;5(1):13-9
19436649
Eur J Clin Pharmacol. 2007 Mar;63(3):307-14
17211620
Diabetes Care. 1997 Oct;20(10):1512-7
9314626
JAMA. 2006 Dec 6;296(21):2563-71
17101639
Eur Heart J. 2007 Jan;28(2):154-9
17158123
Prev Cardiol. 2007 Fall;10(4):190-5
17917515
J Clin Hypertens (Greenwich). 2007 Mar;9(3):179-86
17344769
Clin Ther. 2001 Aug;23(8):1296-310
11558866
Med Care. 2005 Jun;43(6):521-30
15908846
J Hypertens. 2009 Apr;27(4):894-901
19300114
J Gen Intern Med. 2005 Apr;20(4):317-23
15857487
Am J Hypertens. 2008 Oct;21(10):1137-43
18654123
Arch Intern Med. 2005 Nov 28;165(21):2508-13
16314548
Eur J Clin Pharmacol. 1999 Sep;55(7):533-6
10501824
BMJ. 1997 Oct 25;315(7115):1057-8
9366733
Adv Ther. 2005 Jul-Aug;22(4):313-56
16418141
Scand J Prim Health Care. 2006 Jun;24(2):110-4
16690560
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011
18425859
Arch Intern Med. 2009 Feb 9;169(3):260-8
19204217
Dtsch Med Wochenschr. 2006 Nov;131(46 Spec No):H28-30
17109246
Drugs Aging. 2001;18(1):63-77
11232739
Am J Med. 2007 Aug;120(8):713-9
17679131
Am Heart J. 2009 Oct;158(4):644-52
19781426
Arch Intern Med. 2007 Sep 10;167(16):1798-803
17846400
Arch Intern Med. 2008 Apr 28;168(8):847-54
18443260
J Am Coll Cardiol. 2006 Dec 5;48(11):2218-22
17161249
N Engl J Med. 2007 Jan 18;356(3):212
17229947
J Natl Med Assoc. 2003 Jan;95(1):17-27
12656446
Lancet. 2005 Dec 10;366(9502):2005-11
16338449
J Gen Intern Med. 2006 Dec;21(12):1215-21
17105519
N Engl J Med. 2005 Aug 4;353(5):487-97
16079372
Lancet. 2006 Aug 19;368(9536):679-86
16920473
Ann Pharmacother. 2005 Jul-Aug;39(7-8):1198-203
15956238